Mismatch repair deficiency is a biomarker for predicting response to cancer immune checkpoint inhibitors. A new study may explain why it can fall short.
A New Biomarker for Response to Checkpoint Inhibitors
Posted in biotech/medical
Posted in biotech/medical
Mismatch repair deficiency is a biomarker for predicting response to cancer immune checkpoint inhibitors. A new study may explain why it can fall short.